SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Stock Warrants | ||
| Number of Shares, Warrants Outstanding Beginning | 10,984,740 | |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 2.67 | |
| Weighted Average Remaining Contractual Life (Years), Outstanding, Ending | 2 years 1 month 20 days | 2 years 4 months 17 days |
| Aggregate Intrinsic Value Outstanding Beginning | $ 507,000 | |
| Number of Shares, Warrants granted | ||
| Weighted-Average Exercise Price, granted | ||
| Number of Shares, Warrants forfeited | ||
| Weighted-Average Exercise Price, forfeited | ||
| Number of Shares, Warrants exercised | ||
| Weighted-Average Exercise Price, exercised | ||
| Number of Shares, Warrants Outstanding Ending | 10,984,740 | 10,984,740 |
| Weighted-Average Exercise Price, Outstanding Ending | $ 2.67 | $ 2.67 |
| Aggregate intrinsic value outstanding ending | $ 0 | $ 507,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when warrants forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|